FIELD: biotechnology, medicine, oncology. SUBSTANCE: invention proposes monoclonal antibody recognizing integrin-associated human protein and inducing apoptosis of nucleus-containing blood cells. Hybridomas MALB-1 and MALB-2 produce monoclonal antibody that is used as agent useful in treatment of myeloid and lymphoid leukosis. EFFECT: valuable medicinal properties of antibody. 9 cl, 1 tbl, 32 dwg, 5 ex
Title |
Year |
Author |
Number |
MODIFIED ANTAGONISTIC ANTIBODY |
2001 |
- Fukusima Naosi
- Tsutija Masajuki
- Uno Sinsuke
- Okhtomo Tosikhiko
- Jabuta Naokhiro
- Tsunoda Khirojuki
|
RU2295537C2 |
DEGRADED ANTIBODY AS TPO AGONIST |
2001 |
- Tsutija Masajuki
- Okhtomo Tosikhiko
- Jabuta Naokhiro
- Tsunoda Khirojuki
- Orita Tetsuro
|
RU2287534C2 |
MONOCLONAL ANTIBODY INTERACTING WITH SURFACE AGENT OF STROMA CELLS AND HYBRIDOMA FOR PRODUCING IT |
1994 |
|
RU2160313C2 |
AGENT USED IN TREATMENT OF LYMPHATIC TISSUE TUMORS |
1998 |
- Koisikhara Jasuo
- Esimura Jasusi
|
RU2177805C2 |
H- AND L-CHAINS OF MONOCLONAL ANTIBODY PM-1 (MONAT) TO HUMAN IL-6R RECEPTOR AND THEIR V-REGION, MODIFIED MONAT, ITS H- AND L-CHAINS AND THEIR V-REGIONS, CDR-SEQUENCE, DNA-SEQUENCE |
1992 |
- Masajuki Tsutija
- Kokh Sato
- Mehri Margaret Bendig
- Stiven Tarran Dzhons
- Zhoze Uil'Jam Saldankha
|
RU2139351C1 |
MONOCLONAL ANTIBODIES CAPABLE OF BINDING WITH AXL PROTEIN AND THEIR APPLICATION |
2008 |
- Kitazava, Takekhisa
- Suzuki, Tsukasa
- Nagakhasi, Sigekhisa
- Mijamoto, Khadzime
|
RU2559530C2 |
PHARMACEUTICAL COMPOSITION FOR PROPHYLAXIS OR TREATMENT OF DISEASES CAUSED BY IL-6 FORMATION |
1995 |
- Tadamitsu Kisimoto
- Asao Katsume
- Khirojuki Saito
|
RU2147442C1 |
DRUGS AGAINST CHRONIC RHEUMATIC ARTHRITIS CONTAINING ANTAGONIST OF IL-6 AS EFFECTIVE COMPONENT |
1995 |
- Tadamitsu Kisimoto
- Masakhiko Mikhara
- Joitiro Morija
- Josijuki Okhsugi
|
RU2147443C1 |
RECONSTRUCTED HUMAN ANTIBODIES SPECIFIC FOR INTERLEUKIN-8 |
1995 |
- Koudzi Matsusima
- Esikhiro Matsumoto
- Esiki Jamada
- Kokh Sato
- Masajuki Tsutija
- Tatsumi Jamazaki
|
RU2159776C2 |
RECONSTRUCTED HUMAN ANTI-HM 1,24 ANTIBODY, DNA ENCODING H- AND L-CHAIN OF HUMAN ANTI-HM 1,24 ANTIBODY, VECTOR, METHOD OF PREPARING RECONSTRUCTED HUMAN ANTI-HM 1,24 ANTIBODY, PHARMACEUTICAL COMPOSITION FOR MYELOMA TREATMENT |
1997 |
- Ono Kojtiro
- Okhtomo Tosikhiko
- Tsutija Masajuki
- Josimura Jasusi
- Kojsikhara Jasuo
- Kosaka Masaaki
|
RU2184147C2 |